« Back to Record
Citation APA

Erdem, R., De Coster, I., Withanage, K., Mercer, L. L., Marchant, A., Taton, M., Cools, N., Lion, E., Cassels, F., Higgins, D., Ivinson, K., Locke, E., Mahmood, K., Wright, P. F., Gast, C., White, J. A., Ackerman, M. M., Konopka-Anstadt, J. J., Mainou, B. B., & Van Damme, P. (2023). Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study. Vaccine, 41(10), 1657-1667. doi:10.1016/j.vaccine.2023.01.048


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/357918

Erdem, R., De Coster, I., Withanage, K., Mercer, L. L., Marchant, A., Taton, M., Cools, N., Lion, E., Cassels, F., Higgins, D., Ivinson, K., Locke, E., Mahmood, K., Wright, P. F., Gast, C., White, J. A., Ackerman, M. M., Konopka-Anstadt, J. J., Mainou, B. B., & Van Damme, P. (2023). Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized study. Vaccine, 41(10), 1657-1667. doi:10.1016/j.vaccine.2023.01.048